研究项目库 / NCT07123155

S-606001用于庞贝病的II 期研究

这是一项关于庞贝病的II 期研究,登记的药物或干预包括S-606001;Placebo,当前状态为招募中。登记地点显示中国Irvine、Gainesville、Atlanta、St Louis等城市有研究中心记录。是否仍有名额以及是否值得进一步询问,需要向研究中心确认。

一分钟看懂

这是一项关于庞贝病的II 期研究,登记的药物或干预包括S-606001;Placebo,当前状态为招募中。登记地点显示中国Irvine、Gainesville、Atlanta、St Louis等城市有研究中心记录。是否仍有名额以及是否值得进一步询问,需要向研究中心确认。

药物或干预

S-606001;Placebo · II 期

中国哪些地方有记录

以下地点来自登记信息,不代表此刻仍有名额;请向研究中心确认最新情况。

  • University of California - Irvine Medical Center · Irvine
  • University of Florida (UF) - Gainesville · Gainesville
  • Emory University Hospital · Atlanta
  • Washington University in St. Louis · St Louis
  • Duke University Medical Center · Durham
  • Cincinnati Children's Hospital Medical Center · Cincinnati
  • University of Pennsylvania · Philadelphia
  • University of Pittsburgh School of Medicine · Pittsburgh
  • Lysosomal and Rare Disorders Research and Treatment Center (LDRTC) · Fairfax
  • UZ Leuven · Leuven
  • Aarhus University Hospital · Aarhus
  • HLC Hopital Pierre Wertheimer · Bron
  • AP-HP Hopital Raymond Poincare · Garches
  • Centre de Reference des Maladies Neuromusculaires et de la SLA - AP-HM Hopital de La Timone · Marseille
  • CHU de Nice - Hopital Pasteur 2 - Centre de reference des Maladies Neuromusculaires · Nice
  • Universitaetsklinikum Halle (Saale) · Halle
  • SphinCS GmbH · Höchheim
  • Klinikum der Ludwig-Maximilians-Universitaet Muenchen · München
  • A.O.U. Policlinico "G. Martino" · Messina
  • AOU Citta della Salute e della Scienza di Torino - Ospedale le Molinette · Torino
  • Erasmus MC · GE Rotterdam
  • Hospital Universitario 12 de Octubre · Madrid
  • Hospital Universitari i Politecnic La Fe · Valencia
  • Queen Elizabeth Hospital Birmingham · Birmingham
  • National Hospital for Neurology & Neurosurgery · London
  • Royal Free London NHS Foundation Trust · London
  • Royal Victoria Infirmary · Newcastle upon Tyne
  • Salford Royal Hospital · Salford

公开的入选条件

  • * Participant must be ≥18 years of age and ≥40 kilograms (kg) of body weight at the time of signing the informed consent.
  • * Participant must have a diagnosis of LOPD based on documentation of 1 of the following:
  • 1. Deficiency of acid alpha-glucosidase (GAA) enzyme
  • 2. GAA genotype
  • * Participant has a %FVC ≥30% and ≤80% in an upright position without mechanical ventilation at screening; or Participant has ≥10% %FVC drop from upright position to supine position and %FVC ≥20% in a supine position.
  • * Participant performs the 6MWT at screening, as determined by the clinical evaluator, and meets all of the following criteria:
  • 1. Screening values of 6-minute walk distance (6MWD) are ≥75 meters
  • 2. Screening values of 6MWD are ≤90% of the predicted value for healthy adults

联系前需要确认

请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。

查看登记信息

登记号:NCT07123155;登记信息更新于 2026-06-23。

查看原始登记记录